Cardiff Oncology, Inc.
NASDAQ:CRDF · NASDAQ Capital Market
-$0.05 today
Vol 1.70M · Avg 1.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-65.95%
Period High
$4.45
Period Low
$1.26
Latest
$1.26
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$283.43M
Forte Biosciences, Inc.
NASDAQ:FBRX
$243.83M
Innate Pharma S.A.
NASDAQ:IPHA
$165.27M
Molecular Partners AG
NASDAQ:MOLN
$154.17M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$109.08M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.67M
PepGen Inc.
NASDAQ:PEPG
$101.68M
Cassava Sciences, Inc.
SAVA
$63.77M
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
$49.65M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest CRDF filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does CRDF have?
Intrinsic Alpha currently shows 20 recent filings for CRDF.
Explore More
Continue the stock analysis
Jump to another research area for this company.